Comparing Injecting Risk Behaviors of Long-Term Injectors with New Injectors in Tehran, Iran

References

• Bautista, C. T., Todd, C. S., Abed, A. M. S., Botros, B. A., Strathdee, S. A., Earhart, K. C., … Scott, P. T. (2010). Effects of duration of injection drug use and age at first injection on HCV among IDU in Kabul, Afghanistan. Journal of Public Health (Oxford, England), 32(3), 336–341. doi:10.1093/pubmed/fdq020
   PubMed Web of Science ®Google Scholar
• Bluthenthal, R. N., Kral, A. H., Erringer, E. A., & Edlin, B. R. (1998). Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995. JAIDS Journal of Acquired Immune Deficiency Syndromes, 18(5), 505–511.
   Web of Science ®Google Scholar
• Bluthenthal, R. N., Kral, A. H., Gee, L., Erringer, E. A., & Edlin, B. R. (2000). The effect of syringe exchange use on high-risk injection drug users: a cohort study. Aids (London, England), 14(5), 605–611.
   PubMed Web of Science ®Google Scholar
• Bryant, J., & Treloar, C. (2008). Initiators: An examination of young injecting drug users who initiate others to injecting. AIDS and Behavior, 12(6), 885–890.
   PubMed Web of Science ®Google Scholar
• Cook, C., Phelan, M., Sander, G., Stone, K., & Murphy, F. (2016). The case for a harm reduction decade: Progress, potential and paradigm shifts. London: Harm Reduction International.
   Google Scholar
• Degenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P., … Larney, S. (2017). Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review. The Lancet Global Health, 5(12), e1192–e1207. doi: 10.1016/s2214-109x(17)30375-3
   PubMed Web of Science ®Google Scholar
• Fuller, C. M., Vlahov, D., Arria, A. M., Ompad, D. C., Garfein, R., & Strathdee, S. A. (2001). Factors associated with adolescent initiation of injection drug use. Public Health Reports, 116(1_suppl), 136–145.
   PubMed Web of Science ®Google Scholar
• Hacker, M. A., Friedman, S. R., Telles, P. R., Teixeira, S. L., Bongertz, V., Morgado, M. G., & Inácio Bastos, F. (2005). The role of “long-term” and “new” injectors in a declining HIV/AIDS epidemic in Rio de Janeiro, Brazil. Substance Use & Misuse, 40(1), 99–123.
   PubMed Web of Science ®Google Scholar
• Jorjoran Shushtari, Z., Noroozi, A., Mirzazadeh, A., Ahounbar, E., Hajbi, A., Najafi, M., … Noroozi, M. (2017). Comparing characteristics of early-onset injection drug users to those with late-onset injection in Kermanshah, Iran. Substance Use & Misuse, 52(6), 754–759.
   PubMed Web of Science ®Google Scholar
• Kelley, M. S., & Chitwood, D. D. (2004). Effects of drug treatment for heroin sniffers: A protective factor against moving to injection? Social Science & Medicine, 58(10), 2083–2092.
   PubMed Web of Science ®Google Scholar
• Latkin, C. A., & Vlahov, D. (1998). Socially desirable response tendency as a correlate of accuracy of self‐reported HIV serostatus for HIV seropositive injection drug users. Addiction, 93(8), 1191–1197.
   PubMed Web of Science ®Google Scholar
• Miller, C. L., Johnston, C., Spittal, P. M., Li, K., LaLiberté, N., Montaner, J. S., & Schechter, M. T. (2002). Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology, 36(3), 737–742.
   PubMed Web of Science ®Google Scholar
• Montain, J., Ti, L., Hayashi, K., Nguyen, P., Wood, E., & Kerr, T. (2016). Impact of length of injecting career on HIV incidence among people who inject drugs. Addictive Behaviors, 58, 90–94.
   PubMed Web of Science ®Google Scholar
• Nelson, K. E., Eiumtrakul, S., Celentano, D. D., Beyrer, C., Galai, N., Kawichai, S., & Khamboonruang, C. (2002). HIV infection in young men in northern Thailand, 1991–1998: Increasing role of injection drug use. Journal of Acquired Immune Deficiency Syndromes, 29(1), 62–68.
   PubMed Web of Science ®Google Scholar
• Noroozi, M., Ahounbar, E., Karimi, S. E., Ahmadi, S., Najafi, M., Bazrafshan, A., … Waye, K. (2017). HIV risk perception and risky behavior among people who inject drugs in Kermanshah, Western Iran. International Journal of Behavioral Medicine, 24(4), 613–618.
   PubMed Web of Science ®Google Scholar
• Noroozi, M., Noroozi, A., Farhoudian, A., Mohammadi, F., Higgs, P., Rahmani, A., … Armoon, B. (2018). Factors associated with HIV testing among people who inject drugs Tehran. Journal of Substance Use, 23(3), 322–326. doi: 10.1080/14659891.2017.1405093
   Web of Science ®Google Scholar
• Noroozi, M., Rahimi, E., Ghisvand, H., Qorbani, M., Sharifi, H., Noroozi, A., … Armoon, B. (2017). Decomposition of economic inequality in needle and syringe programs utilization to its determinants among men who inject drugs in tehran using blinder–oaxaca decomposition method. Substance Use & Misuse, 53(7), 1170–1176.
   PubMed Web of Science ®Google Scholar
• Rahimi-Movaghar, A., Amin-Esmaeili, M., Shadloo, B., Noroozi, A., & Malekinejad, M. (2015). Transition to injecting drug use in Iran: A systematic review of qualitative and quantitative evidence. International Journal of Drug Policy, 26(9), 808–819.
   PubMed Web of Science ®Google Scholar
• Razzaghi, E., Nassirimanesh, B., Afshar, P., Ohiri, K., Claeson, M., & Power, R. (2006). HIV/AIDS harm reduction in Iran. The Lancet, 368(9534), 434–435.
   PubMed Web of Science ®Google Scholar
• Rezaei, F., Noroozi, A., Armoon, B., Farhoudian, A., Massah, O., Sharifi, H., … Noroozi, M. (2017). Social determinants and hepatitis C among people who inject drugs in Kermanshah, Iran: Socioeconomic status, homelessness, and sufficient syringe coverage. Journal of Substance Use, 22(5), 474–478.
   Web of Science ®Google Scholar
• Sanchez, J., Page, J., Chitwood, D., McBride, D., Kitner, K., & Comerford, M. (2000). First injection and current risk factors for HIV among new and long-term injection drug users. AIDS Care, 12(3), 313–320.
   PubMed Web of Science ®Google Scholar
• Sharifi, H., Mirzazadeh, A., Noroozi, A., Marshall, B. D. L., Farhoudian, A., Higgs, P., … Noroozi, M. (2017). Patterns of HIV risks and related factors among people who inject drugs in Kermanshah, Iran: A latent class analysis. Journal of Psychoactive Drugs, 49(1), 69–73.
   PubMed Web of Science ®Google Scholar
• Thorpe, L. E., Ouellet, L. J., Levy, J. R., Williams, I. T., & Monterroso, E. R. (2000). Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997–1999. The Journal of Infectious Diseases, 182(6), 1588–1594.
   PubMed Web of Science ®Google Scholar
• Uusküla, A., Raag, M., Marsh, K., Talu, A., Vorobjov, S., & Des Jarlais, D. (2017). HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic. PLoS One, 12(2), e0170956.
   PubMed Web of Science ®Google Scholar